Global /China /Healthcare /Drug Manufacturers - General /000650

Renhe Pharmacy Co.,Ltd

000650

• SHE: 000650 • Delayed

5.69CNY -0.2%

0.8408 USD

As of 15 June 2026, Renhe Pharmacy Co.,Ltd has a market cap of $1.17B USD, ranking #9860 globally and #2712 in China. It ranks #861 in the Healthcare sector, and #323 in the Drug Manufacturers - General industry.

Global Rank

9860

Country Rank

2712

Sector Rank

861

Industry Rank

323

Key Stats

Market Cap

$1.17BUSD

7.89B CNY

Enterprise Value

$673.67MUSD

4.56B CNY

Revenue (TTM)

$543.78MUSD

3.68B CNY

EBITDA (TTM)

$123.85MUSD

838.16M CNY

Net Income (TTM)

$54.57MUSD

369.28M CNY

EBITDA Margin

23%

Profit Margin

10%

PE Ratio

21.7

PS Ratio

2.1

PB Ratio

1.1

EV/EBITDA

5.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Wujun Huang open_in_new

Employees

5,394

Founded

1996

Website

renheyaoye.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.2%	1.3%	0.2%	-5.6%	-7.5%	1.1%	6.1%	-13%	-31%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	000650 仁和药业股份有限公司 Class A ISIN: CNE000000NF8 Shares Out.: Shares Outstanding: 1.391B¹ Shares Float: 956.758M² TV: TradingView: SZSE: 000650 SA: Stock Analysis: SHE: 000650 YF: Yahoo Finance: 000650.SZ GF: Google Finance: SHE: 000650 BA: Barron's: 000650 MS: Morningstar: XSHE: 000650	5.69 CNY	TV: TradingView: SZSE: 000650 SA: Stock Analysis: SHE: 000650 YF: Yahoo Finance: 000650.SZ GF: Google Finance: SHE: 000650 BA: Barron's: 000650 MS: Morningstar: XSHE: 000650

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Renhe Pharmacy Co.,Ltd

Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is based in Nanchang, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.92B 364.89B CNY 5K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.7B 336.36B CNY 4K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 2K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.53B 111.89B CNY 1K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 1K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 65K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 47K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 31K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 27K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 25K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 23K%	20.5	Switzerland

chevron_leftBack